AzTrials
AzTrials

Caregiver Burden of People With DementiaNCT06747637

Demonstrating the Efficacy of a Spanish-Language Program for Latino Dementia Caregivers

A study testing Skill-building classes in people with Caregiver Burden of People With Dementia, run by University of Southern California at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The investigators will test the efficacy of Unidos en el Cuidado® (United in Caring, herein Unidos), a 3-session, culturally-adapted, group psychoeducational and skill-building intervention for 226 Spanish-speaking family caregivers in California. Read more about this study

Who is it for?
Ages 18 to 100 yearsHealthy volunteers can take part
Conditions the study is for
Caregiver Burden of People With Dementia
What is being tested?
Skill-building classes
Could I receive a placebo?
No, everyone receives an active treatment
How many people
225 participants
Where
1 siteUnited States
Study dates
4 Jun 2025to 30 Jun 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • identifies with being Hispanic or Latino descent
  • speaks and reads Spanish
  • dementia family caregivers living (or recently lived) in California or whose care recipient lives (or recently lived) in California
  • who identify as women, men, or non-binary,
  • age 18 years or older

Who cannot join

  • Severe sensory or physical conditions that interfere with ongoing participation.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Maria P Aranda, PhD contact

(213) 740-1887

aranda@usc.edu

United States1 site, 1 recruiting
  • University of Southern California

    Los Angeles, California, 90089

    Maria P Aranda, PhD, 213-740-1887, aranda@usc.edu

    Recruiting

Other trials in United States

About this study

Official title: Demonstrating the Efficacy of "Unidos en el Cuidado" (United in Caring): A Spanish-Language Program for Latino Caregivers of Persons Living With Dementia

The investigators will test the efficacy of Unidos en el Cuidado® (United in Caring, herein Unidos), a 3-session, culturally-adapted, group psychoeducational and skill-building intervention for 226 Spanish-speaking family caregivers in California.

Read the detailed description

The investigators will test the efficacy of Unidos en el Cuidado® (United in Caring, herein Unidos), a 3-session, culturally-adapted, group psychoeducational and skill-building intervention for 226 Spanish-speaking family caregivers in California.

Based on a wait list trial design, and 4 observation points (baseline, post-intervention, 3-month and 6-month follow-ups), the investigators propose to demonstrate the efficacy of this new intervention (Aim 1), and evaluate for potential moderating conditions across subgroups (Aim 2; age, gender, educational level, etc.). Based on this quantitative component, the investigators will answer the following two aims:

Aim #1. (Efficacy) Compared to a waitlist control group, is Unidos efficacious with regards to primary outcomes-PHQ-9 depression symptoms, RMBPC reactivity to memory and behavior problems, anxiety symptoms, and secondary outcomes-caregiver mastery, competence, and meaning over time?

Aim #2: (Moderators). Do moderating conditions exist such that the intervention is more or less efficacious for subgroups based on age, gender, PLWD functioning?

Qualitative component: After class completion, the investigators will draw from 40-50 focus group participants to elucidate the satisfaction and acceptability of the program. Both Unidos and wait list control participants will be randomly selected for focus group interviews which will be guided by open-ended inquiries around the nuanced, in-depth perspectives of program participation, acceptability, and recommendations (Aim 3).

Aim #3: (Experience/Satisfaction). Will qualitative reports from focus groups signal satisfaction, nuanced differences with respect to the nature, structure, cultural/ language considerations of Unidos, and recommendations?

Based on the scientific team and community partner's established expertise in dementia care, caregiving services, and underrepresented groups, the project is well positioned to address the linguistic and cultural preferences and needs of diverse Californians and the providers that serve them.

Being tested
Skill-building classes, Wait list control group
Keywords
wait list control interventional study

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Skill-building classesOther

    Unidos en el Cuidado is a manualized, multi-family group intervention provided at no cost vis-à-vis videoconferencing or on-site by trained facilitators Sessions are held weekly for 1.5 hours. Class components include caregiver role identity; skills-building; knowledge attainment; attitudinal changes; resource-sharing; practice/role-plays; homework; videos, handouts. Classes will be provided online with some classes offered in the community, if available

  • Wait list control groupOther

    The intervention is the same; the wait period is longer to receive the intervention described in Group A.

Study groups in NCT06747637
Study groupRoleWhat they receive
Group A: Treatment Group Receives the Classes Soon after RandomizationExperimentalThe Spanish-language caregiver classes are called Unidos en el Cuidado and are taught online by Alzheimer's Los Angeles. Sessions are provided at no cost and held weekly for about 2 hours.
Receives: Other: Skill-building classes
Group B: Wait List Control Group Receives the Classes after a Waiting PeriodActive comparatorThis wait list control group receives the same classes but after a 3-4 week waiting period.
Receives: Other: Wait list control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depressive symptoms

    Patient Health Questionnaire 9 item standardized scale: min. to max values=0 to 27; higher values indicate worse outcomes

    Measured: baseline; post-intervention (within 1 week of completing intervention); 3-months; 6-months from baseline

  2. Presence and reaction to memory and behavior problems shown by person with dementia

    Revised Memory and Behavior Problems Checklist standardized scale:

    1. Symptom presence (yes/no); min. to max values=0 to 24; higher values indicate worse outcomes
    2. Symptom reaction: Include only items with frequency scores of 1 to 4 in the reaction scoring. Compute the mean reaction score by summing reaction scores of these items and then dividing by the number of items included in the sum. the range for each subscale is 0 to 4. Higher values indicate worse outcomes

    Measured: baseline; post-intervention (within 1 week of completing intervention); 3-months; 6-months from baseline

  3. Anxiety symptoms

    Generalized Anxiety Disorder 7 item standardized scale: min. to max values=0 to 24; higher values indicate worse outcomes

    Measured: baseline; post-intervention (within 1 week of completing intervention); 3-months; 6-months from baseline

Secondary outcomes (3)
  1. Caregiver Mastery

    Caregiver Mastery standardized scale: min. to max values=0 to 12; higher values indicate better outcomes

    Measured: baseline; post-intervention (within 1 week of completing intervention); 3-months; 6-months from baseline

  2. Caregiver Competence

    Caregiver Competence standardized scale: min. to max values=0 to 12; higher values indicate better outcomes

    Measured: baseline; post-intervention (within 1 week of completing intervention); 3-months; 6-months from baseline

  3. Caregiver Meaning

    Caregiver Meaning standardized scale: min. to max values=0 to 24; higher values indicate better outcomes

    Measured: baseline; post-intervention (within 1 week of completing intervention); 3-months; 6-months from baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2024
  2. Study start4 Jun 2025 (estimated)
  3. Primary completion30 Jun 2028 (estimated)
  4. Study completion30 Jun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
225 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06747637
Sponsor's protocol ID
AWD-00008709
Status last verified
Jun 2025
First submitted
11 Dec 2024
Last updated
6 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Griffiths PC, Kovaleva M, Higgins M, Langston AH, Hepburn K. Tele-Savvy: An Online Program for Dementia Caregivers. Am J Alzheimers Dis Other Demen. 2018 Aug;33(5):269-276. doi: 10.1177/1533317518755331. Epub 2018 Mar 16.

    PubMed 29544342

Questions about this trial

What is this clinical trial studying?

A study testing Skill-building classes in people with Caregiver Burden of People With Dementia, run by University of Southern California at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Maria P Aranda, PhD ((213) 740-1887, aranda@usc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depressive symptoms (time frame: baseline; post-intervention (within 1 week of completing intervention); 3-months; 6-months from baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06747637, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in